Back to search results
Inactive
Last updated: April 9, 2025

Microsphere-Based Biodegradable Implant

  • User: Female
  • Hormonal: Hormonal
  • Delivery type:
    • Subdermal
  • Intended Duration:
    • Long-Acting
  • Development Stage: Discovery & Early Development
  • Developer(s)/researcher(s): FHI 360, University of Washington
Details
  • API: Levonorgestrel
  • Target: Progesterone Receptor, Androgen Receptor
  • Mechanism of Action:
    • Ovulation Inhibition
    • Cervical Mucus Changes
    • Endometrial Changes
  • Inactive Materials: PLGA
  • Regimen: 1 Insertion/18 Months
  • MPT: Potential MPT
Product Status

While the Ratner group is still exploring biodegradable PLGA, this product is not referenced on the lab site and FHI 360 is no longer supporting this platform

History

Originally conceptualized by the Ratner Group at the University of Washington